Literature DB >> 21883816

Robot-assisted partial nephrectomy for sporadic ipsilateral multifocal renal tumours.

Humberto Laydner1, Riccardo Autorino, Gregory Spana, Fatih Altunrende, Bo Yang, Rakesh Khanna, Michael A White, Wahib Isac, Shahab Hillyer, Georges-Pascal Haber, Robert J Stein, Jihad H Kaouk.   

Abstract

OBJECTIVE: To report our short-term results of robot-assisted partial nephrectomy for treating sporadic multiple ipsilateral renal tumours.
METHODS: Over a 3-year period, eight patients with two or more ipsilateral renal masses underwent nine robotic partial nephrectomies in our institution. We evaluated the PADUA and R.E.N.A.L. nephrometry scores, intraoperative outcomes, histopathological characteristics, complications according to Clavien classification and renal function outcomes.
RESULTS: In total, 19 tumours were removed from eight patients in nine procedures. Mean operative time was 199 ± 47 min (median 200; range 150-300). Mean size of the dominant lesion was 3.0 ± 1.1 cm (2.7; 1.6-4.8) and overall mean tumour size was 2.2 ± 1.2 cm (1.9; 0.4-4.8). Mean number of tumours removed per patient was 2.4. Median PADUA and R.E.N.A.L. scores were 7 and 6 (with the predominance of an anterior, non-hilar position), respectively. Excluding the six off-clamp resected tumours, the mean warm ischaemia time was 21 ± 9.2 min (21; 10-35). Mean estimated blood loss was 250 ± 154 mL (200; 100-500) and no patient required transfusion. There were no intraoperative complications or conversion to open surgery. One patient had atrial fibrillation, resolved with anti-arrhythmic drugs. Mean length of stay was 4.2 ± 0.97 days. Sixteen of the nineteen tumours were malignant, most of papillary type and Fuhrman grade II. The mean decrease in glomerular filtration rate was 4%, with a mean follow-up of 14 months.
CONCLUSIONS: Robotic partial nephrectomy for sporadic ipsilateral multifocal renal tumours is feasible and safe. Off-clamp resection of multiple tumours can also be safely performed in carefully selected lesions.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21883816     DOI: 10.1111/j.1464-410X.2011.10319.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Endoscopic robot-assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative results.

Authors:  Andrea Minervini; Agostino Tuccio; Lorenzo Masieri; Domenico Veneziano; Gianni Vittori; Giampaolo Siena; Mauro Gacci; Graziano Vignolini; Andrea Mari; Arcangelo Sebastianelli; Matteo Salvi; Sergio Serni; Marco Carini
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

2.  A propensity-score matched comparison of perioperative and early renal functional outcomes of robotic versus open partial nephrectomy.

Authors:  Zhenjie Wu; Mingmin Li; Le Qu; Huamao Ye; Bing Liu; Qing Yang; Jing Sheng; Liang Xiao; Chen Lv; Bo Yang; Xu Gao; Xiaofeng Gao; Chuanliang Xu; Jianguo Hou; Yinghao Sun; Linhui Wang
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

3.  Zero ischaemia laparoscopic nephron-sparing surgery by re-suturing.

Authors:  Jinshan Lu; Qiang Zu; Qingshan Du; Yong Xu; Xu Zhang; Jun Dong
Journal:  Contemp Oncol (Pozn)       Date:  2014-11-05

4.  Combined Robotic Surgery for Double Renal Masses and Prostate Cancer: Myth or Reality?

Authors:  Giovanni Cochetti; Diego Cocca; Stefania Maddonni; Alessio Paladini; Elena Sarti; Davide Stivalini; Ettore Mearini
Journal:  Medicina (Kaunas)       Date:  2020-06-26       Impact factor: 2.430

Review 5.  Robotic partial nephrectomy: The new horizon.

Authors:  Humberto Laydner; Jihad H Kaouk
Journal:  Arab J Urol       Date:  2011-12-20

6.  Robotic-assisted partial nephrectomy with sequential clamping of segmental renal arteries for multiple ipsilateral renal tumors: initial outcomes.

Authors:  Jie Yang; Jia-Dong Xia; Jian-Xin Xue; Ning-Hong Song; Chao Liang; Di Xi; Ya-Min Wang; Zeng-Jun Wang
Journal:  BMC Urol       Date:  2019-05-03       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.